Speakers

Dr Ulrich Kissel

Dr Ulrich Kissel

European QP Association (EQPA), KisselPharmaConsulting

Dr Fatima Bicane

Dr Fatima Bicane

Pharma Deutschland

GMP-RELATED CHANGES AND AMENDMENTS IN THE NEW REGULATION AND DIRECTIVE


Target Group

  • Professionals involved in GMP-relevant activities within the pharmaceutical Industry
  • Personnel responsible for preparing for or implementing regulatory updates in their organisations
  • Anyone who wants an overview of the expected GMP-related changes proposed in the revision of EU Medicines Legislation

Objectives

On 10th December 2025 co-legislators reached a provisional agreement on revamping the EU’s pharmaceutical policy framework, to boost competitiveness, innovation and security of supply.

The reform aims to improve availability, accessibility and affordability of medicines, while promoting higher environmental standards and increasing competitiveness of the pharmaceutical industry in the EU. Key elements include reducing administrative burdens, promoting innovation and competitiveness, addressing shortages, ensuring environmental sustainability and tackling antimicrobial resistance.

There are also GMP-relevant changes, which will be discussed in this Live Online Session.


Programme

Status and Overview of the Revision of the Pharmaceutical Legislation in the EU
  • Part I: Legal Instrument and legislative process
  • Part II: New Directive of the European parliament and the council on the Union code relating to medicinal products for human use
  • Part III: New Regulation of the European parliament and the council laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency
GMP-relevant Consequences from Directive and Regulation
  • The manufacturer, the QP and the new directive 2023/192
  • The manufacturer, the QP and the new regulation 2023/193
  • Discussion and observations
  • The QP and the new Annex III to directive 2023/192
  • ECA-EQPA comments
  • Early and expected impacts on GMP rules and applicability
  • Conclusion


Further Information

Technical Requirements
We use Webex for our live online training courses and webinars. At www.gmp-compliance.org/training/online-training-technical-information you will find all the information you need to participate in our events and you can check if your system meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. Webex is a standard nowadays and the necessary installation is fast and easy.
 
Fees (per delegate, plus VAT)
ECA Members EUR 590
APIC Members EUR 640
Non-ECA Members EUR 690
EU GMP Inspectorates EUR 590
The conference fee is payable in advance after receipt of invoice.
The Registration does not include ECA Membership.
 
Presentations/Certificate
The presentations will be made available to you prior to the Live Online Training as PDF files. After the event, you will automatically receive your certificate of participation.

Conference language
The official conference language will be English.

Contacts
Questions regarding content:
Mr Wolfgang Schmitt, +49 6221 84 44-39, w.schmitt@concept-heidelberg.de
Questions regarding organisation:
Ms Manuela Luckhaupt, +49 6221 84 44-66, luckhaupt@concept-heidelberg.de


Date & Time

Tue, 17 March 2026
13:00–17:45 h
All times mentioned are CET.

Costs

ECA-Member*: € 590,-
Regular Fee*: € 690,-
EU/GMP Inspectorates*: € 590,-
APIC Member Discount*: € 640,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Recording/ Additional dates on-site
not available
Recording/ Additional dates on-site
not available
Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

“I found the course eye opening and very well organized.”

Jozsef Maklary, Veolia Industries Austria GmbH
The GMP-Compliance Manager, October 2025

"I am so grateful for having attended this course. Great job from all, and very profitable. Thanks!”

Alba Aranda Cuesta, Kern Pharma
KPIs and Quality Metrics, Berlin, Germany, April 2025

"The lectures were very informative, interesting and entertaining."

Albert Godoy Hernández, Company synaffix
Live Online Training - GMP Auditor Practice, October 2024

"Really useful training which I will use in my daily work."

Regina Mommaerts, Galapagos NV
Live Online Training - GMP Auditor Practice, October 2024

"Wonderful format of the sessions: Good range of participations and experience in the team. Would love to attend another one soon."

Roopasi Mathi, Wacker Biotech B.V.
Live Online Training - GMP Auditor Practice, October 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Both, organizers and lecturers were very friendly, open for discussions and extremely constructive. The course was a valuable experience for me.”

Maria Dimitrova, NKN Law Firm
Pharmaceutical Contracts: GMP and Legal Compliance, March 2025